MSK is proud to announce that four Sloan Kettering Institute (SKI) researchers have been named 2025 Marie-Josée Kravis Women ...

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...

MSK researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Our radiation oncologists use the latest technology available for radiation therapy. It’s important to understand how radiation therapy fits into your treatment plan so you can make choices about your ...

Research at MSK Our research impact Research topics Core facilities & resources ...

A phase 3 trial for myelofibrosis found that adding pelebresib to ruxolitinib was more effective than ruxolitinib alone and did not significantly increase side effects.

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Research at MSK Our research impact Research topics Core facilities & resources ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Research at MSK Our research impact Research topics Core facilities & resources ...